Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

Home > What's New > Past Science Meetings    

Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Addiction Treatment



Speaker Biographies

Leslie Amass, Ph.D.
Principal Investigator
Friends Research Institute, Inc.
Suite 200
11075 Santa Monica Boulevard
Los Angeles, CA 90025
(310) 312-0500, ext. 352
(310) 312-0552 Fax
lamass@friendsresearch.org

Dr. Amass is Principal Investigator at the Friends Research Institute, Inc., in Los Angeles. She specializes in evaluating novel pharmacological and behavioral treatments for substance dependence. A primary focus of her work has been evaluating buprenorphine and buprenorphine/naloxone for opioid maintenance and detoxification treatment and examining cost-effective strategies for transporting behavioral therapies into community practice. Dr. Amass is National Project Director and Co-Principal Investigator for the three buprenorphine/naloxone detoxification protocols for the NIDA Clinical Trials Network. These multicenter research-to-practice evaluations will identify optimal methods for buprenorphine/naloxone detoxification in more than 1,500 patients and 25 U.S. community-based treatment programs. She is also Principal Investigator of a NIDA R01 grant to study the transfer of voucher-based reinforcement therapy into community treatment settings as well as Principal Investigator of a Phase II evaluation of selegiline for cocaine-dependence treatment.


Anthony Benedetto, CSW, CASAC
Assistant Vice President, Clinical Services
Samaritan Village, Inc.
13802 Queens Boulevard
Briarwood, NY 11435
(718) 2062000, ext. 265
(718) 2064055 Fax
janetabene@samvill.org

Mr. Benedetto is Assistant Vice President of Clinical Services at Samaritan Village, Inc. He has been involved in developing and managing intensive outpatient treatment programs, department of corrections discharge planning programs, department of homeless services treatment shelters, and a program for homeless veterans with coexisting substance abuse and mental health issues. During Mr. Benedetto's tenure with Montefiore Hospital's jail-based mental health services, he developed and delivered a curriculum for New York City corrections officers on recognizing and dealing with behavioral emergencies in corrections settings. Previous presentations include cofacilitating international training seminars on the history and concepts of the therapeutic community to mental health and substance abuse treatment professionals in Brazil, Colombia, and Uruguay and "Outpatient Alternatives to Incarceration and Outpatient Services for Pregnant Addicted Women" at the 1992 World Federation of Therapeutic Communities Conference in Venice, Italy. Mr. Benedetto also presented a paper on cocaine abuse among mass transit employees at the First Nordic Conference on Cocaine in Gothenburg, Sweden, in 1989.

View Presentation [PDF Format, 136K]


Kathleen Theresa Brady, M.D., Ph.D.
Director
South Carolina Node, NIDA Clinical Trials Network
Professor of Psychiatry
Department of Psychiatry
Medical University of South Carolina
Ralph H. Johnson Veterans Affairs Medical Center
Room 523B
109 Bee Street
Charleston, SC 29401
(843) 7925205
(843) 7923982 Fax
bradyk@musc.edu

Dr. Brady is active in research and teaching as Professor of Psychiatry in the Department of Psychiatry, Center for Drug and Alcohol Programs, Medical University of South Carolina (MUSC), where she is also Director of the Addiction Psychiatry Fellowship Program. She has authored more than 120 publications in the area of psychiatric disorders and substance abuse. Dr. Brady earned her Ph.D. degree in pharmacology from the Medical College of Virginia, where she conducted basic science work with substances of abuse. She also completed medical school, a residency in psychiatry, and a fellowship in substance abuse at MUSC. Dr. Brady's areas of special interest include the comorbidity of substance use disorders with anxiety and affective and psychotic disorders and the pharmacotherapy of substance use disorders.


Ronald Brady, M.D.
Director of Medicine and Research
Bridge Plaza Treatment and Rehabilitation Clinic
3718 34th Street
Long Island City, NY 11021
(718) 7863921
(718) 7862116 Fax
ronbrady@optonline.net

Dr. Brady is Director of Medicine and Research at the Bridge Plaza Treatment and Rehabilitation Clinic, a division of Narco Freedom, Inc., in New York City. He is also Assistant Professor of Psychiatry at Columbia University and President of Addiction Management Systems. A psychiatrist by training, one of Dr. Brady's interests is raising the quality of patient care and enhancing substance abuse services through the development of automated dispensing and clinical management software. In addition, he has conducted research on depression among methadone patients, polydrug use, the effect of HIV medications on serum methadone levels, and Phase I and II studies testing a new medication useful in regulating gastrointestinal motility disorders among methadone maintenance patients. Dr. Brady is also Site Investigator for the Long Island Regional Node of NIDA's Clinical Trials Network. He invented the automated dispensing system that is currently in use in some 400 clinics throughout the United States.


Susan Brandau
Project Director
Practice Improvement Collaborative
New York State Office of Alcoholism and Substance Abuse Services
1450 Western Avenue
Albany, NY 12203
(518) 457-6129
(518) 457-5674 Fax
susanbrandau@oasas.state.ny.us

Ms. Brandau is Project Director of the New York State (NYS) Practice Improvement Collaborative (PIC), a joint initiative of the NYS Office of Alcoholism and Substance Abuse Services (OASAS) and the Alcoholism and Substance Abuse Providers of NYS. The PIC is funded by the Center for Substance Abuse Treatment and was developed to initiate and sustain community-based efforts to improve substance abuse treatment through the adoption of evidence-based practices. Ms. Brandau coordinates a network of more than 500 treatment and prevention professionals and addiction researchers who are members of the eight regional Pratice Research Networks that were developed to provide the infrastructure necessary to facilitate long-term collaboration between researchers and practitioners.


Allen Bray, M.H.S.
Self Help Addiction Rehabilitation, Inc.
1852 West Grand Boulevard
Detroit, MI 48208
(313) 894-1445
(313) 894-5542 Fax
sharorg@aol.com


Vincent Brewington, M.A.
Grants Management Officer
Lincoln Medical and Mental Health Center
Room 734
234 East 149th Street
Bronx, NY 10451
(718) 579-5402
(718) 579-5326 Fax
vbrewington@msn.com

Mr. Brewington is Grants Management Officer of the Generations Health Plus/Northern Manhattan Health Network, which is part of the New York City Health and Hospitals Corporation and comprises three municipal hospitals (Lincoln, Harlem, and Metropolitan), three diagnostic and treatment centers, and 38 clinics and school-based programs located in northern Manhattan and the south Bronx. His background includes hospital administration, substance abuse treatment, and research, and he was Clinical Supervisor of Lincoln Hospital's Substance Abuse Division for 7 years. As a researcher with the National Development and Research Institutes, Inc. (1985-1991), Mr. Brewington was Project Director of a controlled study evaluating acupuncture for cocaine/crack detoxification. His research and publications have focused on substance abuse treatment issues. Mr. Brewington has a master's degree in experimental psychology.


Lawrence S. Brown, Jr., M.D., M.P.H.
Senior Vice President
Division of Medical Services, Evaluation and Research
Addiction Research and Treatment Corporation
22 Chapel Street
Brooklyn, NY 11201
(718) 260-2917
(718) 522-3186 Fax
lbrown@artcny.org

Dr. Brown is a physician-researcher with training in internal medicine, neuroendocrinology, and addiction medicine. He is Senior Vice President of the Addiction Research and Treatment Corporation in Brooklyn, New York, and President-elect of the American Society of Addiction Medicine (ASAM). Dr. Brown also has appointments as Visiting Physician at Rockefeller Hospital and Clinical Associate Professor of Public Health at Weill Medical College, Cornell University. He is a member of the board of directors of the U.S. Anti-Doping Agency and the ASAM Board of Trustees. Dr. Brown provides consultation to a host of government and private agencies, including serving as Medical Advisor to the National Football League. His current responsibilities include providing medical care to patients, teaching young physicians and medical students, supervising the administrative support for and delivery of medical care to opiate-addicted patients, and conducting biomedical and behavioral research. Dr. Brown's scientific contributions have focused on the sequelae of, as well as improving the treatment of, drug addiction and drug abuse-related HIV transmission. He has made presentations at national scientific, public health, and medical meetings and has authored more than 40 peer-reviewed articles, 10 book chapters, and 100 published abstracts.


Gregory C. Bunt, M.D.
Medical Director
Daytop Village
500 Eighth Avenue
New York, NY 10018
(212) 904 1500, ext. 243
(212) 904 1743 Fax
gbunt@daytop.org

Dr. Bunt obtained his medical degree in 1983 from New York University (NYU) and completed his residency in psychiatry at the Albert Einstein College of Medicine in 1987. He was among the first group to complete the Fellowship in Addiction Psychiatry at NYU (1989) and has been on the NYU Medical School faculty in the Division of Addiction Psychiatry, currently as Assistant Professor. Dr. Bunt is a diplomat of the American Board of Psychiatry and Neurology, with additional qualifications in addiction psychiatry. He is Medical Director of Daytop Village, one of the largest and most well-established therapeutic communities for drug rehabilitation. Dr. Bunt also serves as Chair of the Committee on Therapeutic Communities of the American Society of Addiction Medicine.

View Presentation [PDF format, 600K]


Judge Alex M. Calabrese, J.D.
Presiding Judge
Red Hook Community Justice Center
New York State Court System
88 Visitation Place
Brooklyn, NY 11231
(718) 923-8225
(718) 923-8248 Fax
mmompela@courts.state.ny.us

Judge Calabrese is Presiding Judge of the Red Hook Community Justice Center, an innovative community court with jurisdiction over criminal, juvenile delinquency, and public housing cases. The Justice Center opened on April 5, 2000, and currently hears cases from New York State's 76th, 78th, and 72nd Precincts. The court mandates participation in numerous onsite services, including substance abuse treatment; job training; individual, group, and family counseling; and adult education programs. These services are also offered to the community on a voluntary basis. Judge Calabrese was appointed Criminal Court Judge for the City of New York in April 1997. Prior to this appointment, he served as Principal Law Assistant to Judge Leslie Crocker Snyder for 11 years. In that capacity, Judge Calabrese worked on complex, multidefendant, organized crime narcotics cases and gang-related homicides. Previously, he was Trial Attorney at the Legal Aid Society's Criminal Defense Division in Manhattan for 6 years. Judge Calabrese is a graduate of the Fordham University School of Law and the University of Notre Dame. He and Judge Snyder wrote Criminal Practice (New York State Bar Association).


Jerome F.X. Carroll, Ph.D.
Consultant
Alcoholism and Substance Abuse Providers of New York State
4318 Atlantic Avenue
Brooklyn, NY 11224
(718) 449-4278
(718) 946-8367 Fax
jfxc4318@aol.com

Dr. Carroll is a consultant in private practice. From 1986 until July 2000, he served as the Project Return Foundation's Vice President for Clinical Operations. Dr. Carroll's career in addiction began in 1971 when he became Director of Psychological Services at Eagleville Hospital and Rehabilitation Center in Pennsylvania. Eagleville was the Nation's first program to consciously and purposefully treat alcoholics and other drug addicts together. Dr. Carroll has conducted research on the mental health-substance abuse interface and on personality and psychopathology differences and similarities between alcoholics and other drug addicts and has conducted program evaluation and treatment outcome studies of program graduates. He has published numerous articles and chapters in professional journals and texts and has lectured and conducted training throughout the United States and abroad. Dr. Carroll also developed the Substance Abuse Problem Checklist and the Mental Health Screening Form-III, instruments designed to help clinicians develop treatment plans and facilitate the counseling process.


Kathleen M. Carroll, Ph.D.
Principal Investigator
New England Node, NIDA Clinical Trials Network
Professor
Department of Psychiatry
Connecticut Veterans Affairs Healthcare System
Yale University School of Medicine
Room 151D
950 Campbell Avenue
West Haven CT 06516
(203) 937-3486, ext. 7403
(203) 937-3472 Fax
kathleen.carroll@yale.edu

Dr. Carroll is Professor of Psychiatry at the Yale University School of Medicine, Director of Psychosocial Research for the Division of Substance Abuse, and Scientific Director of the Center for Psychotherapy Development for Opioids and Cocaine at Yale. She is also Associate Editor of Psychological Assessment and serves on the editorial boards of several other journals. Dr. Carroll is Principal Investigator of the New England Node of the NIDA Clinical Trials Network (CTN) and Lead Investigator of the CTN trials evaluating the effectiveness of motivational interviewing in real-world settings. She is the author of more than 150 journal articles and chapters. Dr. Carroll's research and clinical interests include specifying and evaluating behavioral treatments for substance users and evaluating combinations of psychotherapy and medications to enhance treatment outcome for addicted persons.

View Presentation [PDF format, 388K]


Paul P. Casadonte, M.D.
Associate Clinical Professor of Psychiatry
Veterans Affairs Medical Center
New York University School of Medicine
Room 116A
423 East 23rd Street
New York, NY 10010
(212) 263-6802
(212) 951-3356 Fax
paul.casadonte@med.va.gov

Dr. Casadonte is Associate Clinical Professor of Psychiatry at the Veterans Affairs Medical Center and New York University School of Medicine and Director of Substance Abuse Treatment Programs at the New York Harbor Healthcare System in Manhattan. He is also Co-Principal Investigator of the New York Node of NIDA's Clinical Trials Network. Dr. Casadonte has been Principal Investigator of multisite clinical trials of LAAM, buprenorphine, and buprenorphine/naloxone since 1990. He is also a member of the faculty of the American Society of Addiction Medicine Subcommittee on buprenorphine training and has been a course director and a faculty member for physician buprenorphine training programs in preparation for the release of these medications in 2002. Dr. Casadonte also maintains a private general psychiatry practice in New York City.

View Presentation [PDF format, 236K]


Anna Rose Childress, Ph.D.
Research Associate Professor
Department of Psychiatry
University of Pennsylvania School of Medicine
Addiction Treatment Research Center
3900 Chestnut Street
Philadelphia, PA 19104-6178
(215) 222-3200
(215) 386-6770 Fax
childress_a@mail.trc.upenn.edu

Dr. Childress has had a career-long focus on drug craving - its measurement, treatment, and most recently, brain substrates. For two decades she has conducted substance abuse treatment and NIDA-funded clinical research with opiate-, cocaine-, and nicotine-dependent populations. Dr. Childress pioneered the use of drug cues to study cue-induced craving in the brain-imaging setting, finding that the same brain circuitry used by natural rewards (e.g., food, sex) was activated during cocaine craving. Her lab has also recently shown that cocaine patients may have defects in the brain's circuitry, making it even more difficult for these patients to handle their impulses to use drugs. Both of these problems must be taken into account for treatment. Dr. Childress is Research Associate Professor of Psychology in the Department of Psychiatry, University of Pennsylvania School of Medicine, and Clinical Psychologist at the Philadelphia Veterans Affairs Medical Center.

View Presentation [PDF fomat, 1.2MB]


Eric Collins, M.D.
Assistant Professor of Clinical Psychiatry
New York State Psychiatric Institute
Columbia University
Unit 120
1051 Riverside Drive
New York, NY 10032
(212) 305-8732
(212) 305-9842 Fax
collins@pi.cpmc.columbia.edu

Dr. Collins is Assistant Professor of Clinical Psychiatry at the Columbia University College of Physicians and Surgeons and Psychiatrist II at the New York State Psychiatric Institute. He completed his psychiatric residency training and a fellowship in substance abuse at the Columbia-Presbyterian Medical Center. Dr. Collins also completed a fellowship in consultation-liaison psychiatry at Columbia and is board certified in psychiatry and addiction psychiatry. He serves as Medical Director of the Cocaine Research Laboratory at Columbia, where he is conducting a clinical trial of heroin detoxification using general anesthesia. Dr. Collins teaches medical students and psychiatry residents at the Medical Center and maintains a small private practice of general and addiction psychiatry. His research interests involve identifying and developing potential new medications for heroin and cocaine dependence. Dr. Collins' clinical interests have focused on addiction, including the clinical questions that emerge in the management of chronic pain with opiate medications.


John J. Coppola, M.S.W.
Executive Director
Alcoholism and Substance Abuse Providers of New York State
1 Columbia Place
Albany, NY 12207
(518) 426-3122
(518) 426-1046 Fax
jcoppola@asapnys.org

Mr. Coppola is Executive Director of the New York Association of Alcoholism and Substance Abuse Providers, Inc. He is responsible for representing the interests of a broad array of alcoholism and substance abuse treatment, prevention, research, and training providers throughout New York State (NYS). Previously, Mr. Coppola was Executive Director of Catholic Charities and served on the Executive Committee of the NYS Association of Substance Abuse Programs. He also served as Chair of the NYS Catholic Conference Alcoholism and Substance Abuse Committee and has held leadership positions on a number of other regional, State, and national committees, including an advisory role with the White House Office of National Drug Control Policy. Mr. Coppola holds a master's degree in social work and a bachelor's degree in psychology.


Thomas A. Coyne, M.S.W.
Director
National Training Services
106 Campbell Street
New Hyde Park, NY 11040
(631) 723-2297
tcoyne@asitraining.com

Mr. Coyne is Founder and Director of National Training Services, an organization providing training and technical assistance in the assessment and treatment of substance abuse and evaluation and outcomes monitoring of its treatment. He is former Associate Director of Technology Transfer at the Treatment Research Institute, where he worked closely with Dr. A. Thomas McLellan and the developers of the Addiction Severity Index. Previously, Mr. Coyne was Director of Training at DeltaMetrics, a clinical information systems and outcomes monitoring firm. He has extensive experience in the design, delivery, and evaluation of training; technical assistance and technology transfer nationally on a variety of topic areas; and projects in the substance abuse and criminal justice field, including the psychopharmacology of addiction, sanctions and incentives, relapse prevention, HIV/AIDS, assessment, and uniform patient placement criteria.


Joy Davidoff, M.P.A.
Coordinator of Addiction Medicine
New York State Office of Alcoholism and Substance Abuse Services
1450 Western Avenue
Albany, NY 122033526
(518) 485-2156
(518) 485-5132 Fax
joydavidoff@oasas.state.ny.us

Ms. Davidoff is Coordinator of Addiction Medicine for the New York State (NYS) Office of Alcoholism and Substance Abuse Services (OASAS). OASAS regulates the largest treatment provider network in the country. As Coordinator, she has been developing an organizational capacity within OASAS to work with providers to integrate emerging addiction medicines into clinical treatment. As former Director and Deputy Director of Policy Analysis and Information for the NYS Division of Parole for a decade, Ms. Davidoff came to OASAS with extensive experience in developing policy and moving it into the stages of program development, implementation, and evaluation.


Jayme A. Delano, CSW
Project Director
Brooklyn Treatment Center
Ninth Floor
360 Adams Street
Brooklyn, NY 11201
(718) 243-2639
(718) 643-4096 Fax
jdelano@courts.state.ny.us

Ms. Delano is Project Director of the Brooklyn Treatment Court. She has a bachelor's degree in criminal justice from Long Island University, C.W. Post Campus, and a master's degree in social work from New York University and is a trained clinical social worker. Ms. Delano has been employed in the human services field for 17 years, providing services to substance-abusing offenders in alternatives to incarceration programs and treating people with mental health disorders in community-based clinics. She is a consultant for the Department of Justice's Drug Courts Professional Office and a faculty member of the National Association of Drug Court Professionals' National Drug Court Institute. Ms. Delano is also a part-time instructor for the Resource Group, an approved educational agency for the New York State Office of Alcoholism and Substance Abuse Services' Certified Alcohol and Substance Abuse Counselor credentialing program. In addition, she is a psychotherapist with a private practice in New York City.

George De Leon, Ph.D.
Director
Center for Therapeutic Community Research
National Development and Research Institutes, Inc.
14th Floor
71 West 23rd Street
New York, NY 10010
(212) 845-4417
(917) 438-0894 Fax
george.deleon@ndri.org

Dr. De Leon is an internationally recognized expert in the treatment of substance abuse and the acknowledged leading authority on treatment and research in therapeutic communities (TCs). He holds a Ph.D. degree in psychology from Columbia University and is Director of the Center for Therapeutic Community Research, which was established by a NIDA-funded grant to the National Development and Research Institutes, Inc. (NDRI). Dr. De Leon has a long association with NIDA as grantee, member, and chair of Internal Review Groups and member of the Advisory Board. He is Clinical Professor of Psychiatry at the New York University School of Medicine, where he provides training in TC practice and research to psychiatric fellows, psychologists, predoctoral and postdoctoral graduates, nurses, and social workers. Dr. De Leon was Vice President and Director of Research and Evaluation at Phoenix House from its inception through 1988 and served as Director of Research and Training at Therapeutic Communities of America (TCA) from 1988 to 1991. He serves as Coordinator of the TCA Subcommittee on Criminal Justice on developing national standards for accreditation of TC programs in correctional settings. Dr. De Leon is an active member of many professional organizations in psychology and psychiatry, including the Subcommittee on Alcohol and Drug Abuse of the New York Academy of Medicine. He has published more than 140 scientific papers and chapters and has authored or edited 4 volumes and 3 NIDA monographs.


Don DesJarlais, Ph.D.
National Development and Research Institutes, Inc.
14th Floor
71 West 23rd Street
New York, NY 10010
(212) 845-4400
desjarlais@ndri.org


Catherine A. Doherty, M.Ed., CPP
Executive Director
Albany Citizens Council on Alcoholism and Other Chemical Dependencies, Inc.
P.O. Box 4007
Albany, NY 12204-0007
(518) 465-5470
(518) 427-0854 Fax
katiedoh@aol.com

Ms. Doherty has served as Executive Director of the Albany Citizens Council on Alcoholism and Other Chemical Dependencies, Inc. (ACCA) for 3 years. ACCA is a nonprofit organization established 35 years ago and is the second largest provider of substance abuse services in the Capital District. ACCA administers four New York State Office of Alcoholism and Substance Abuse Services (OASAS)-licensed and -certified outpatient, detox, residential, and educational programs. Ms. Doherty is a nationally recognized consultant and speaker on the topic of substance abuse prevention education and research. She is the author of the nationally known prevention education program "An Apple A Day," which has been endorsed by the Office of the Surgeon General, and the coauthor of "GROW GIRL!," a self-esteem-building program for adolescent girls endorsed by the Center for Substance Abuse Prevention. Mrs. Doherty has conducted extensive research in the prevention field regarding risk and protective factors and the efficacy of using literacy as a tool to prevent substance abuse. She has served as a consultant to Federal, State, and county agencies and is a member of the OASAS Academy of Addiction Studies. As ACCA Executive Director, Ms. Doherty has forged and fostered many collaborations between private and public agencies to enhance the delivery of more efficient and comprehensive substance abuse and prevention services in the Albany community. She researched and developed the protocol for the GreenLight Case Management Program, a model case management program that focuses on the most difficult clients, whose histories of relapse or resistance to treatment require intensive assistance to remove treatment barriers. GreenLight is cost efficient and effective in utilizing treatment resources and services in the mental health system. Mrs. Doherty holds two master's of education degrees and is a student in the doctoral program at the University of Massachusetts.

View Presentation [PDF format, 992K]


Stephen J. Donovan, M.D.
Research Psychiatrist
New York State Psychiatric Institute
Unit 51
1051 Riverside Drive
New York, NY 10032
(212) 543-5768
(212) 543-5326 Fax
sd45@columbia.edu

Dr. Donovan is Research Psychiatrist at the New York State Psychiatric Institute and Assistant Professor of Clinical Psychiatry at Columbia University. He received an Independent Scientist Award from NIDA to study the pharmacology of addiction risk factors. Dr. Donovan is board certified by the American Board of Medical Specialists in Child and Adolescent Psychiatry, Adult Psychiatry, and Addiction Psychiatry. He is also a graduate psychoanalyst and member of the American Psychoanalytic Association. Dr. Donovan has extensive experience in clinical trials of medications for depression, temper outbursts, and irritable mood swings. He is particularly interested in the response of temper and irritable mood in children and adolescents to mood stabilizers as well as the relationship between irritable mood swings and marijuana abuse.

View Presentation [PDF format, 132K]


What's New Contents


Blending Conference Bridge Logo

Sponsored by
National Institute on Drug Abuse
National Institutes of Health
Department of Health and Human Services

In partnership with
The New York CTN Node/New York University School of Medicine
The Long Island CTN Node/Columbia University and New York State Psychiatric Institute
New York State Office of Alcoholism and Substance Abuse Services
Alcoholism and Substance Abuse Providers of NYS
Northeast Addiction Technology Transfer Center (ATTC)
New York State Practice Improvement Collaborative (PIC)



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal